Microalbuminuria and essential hypertension: Renal and cardiovascular implications

Current Opinion in Nephrology and Hypertension

Volumn 6, Issue 6, 1997, Pages 551-557

  Luft, Friedrich C ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY RISK; ESSENTIAL HYPERTENSION; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MICROALBUMINURIA; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RETINOPATHY; REVIEW; SMOKING CESSATION; ALBUMINURIA; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; FEMALE; HYPERTENSION; MALE; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY;

ALBUMINURIA; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; MALE; PRE-ECLAMPSIA; PREGNANCY;

EID: 0031264627     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199711000-00010     Document Type: Review

References (27)

1. Pedrinelli R: Microalbuminuria in hypertension. Nephron 1996, 73:499-505.
2. Pontremoli R: Microalbuminuria in essential hypertension: its relation to cardiovascular risk factors. Nephrol Dial Transplant 1996, 11:2113-2134.
3. Parving H-H: Microalbuminuria In essential hypertension and diabetes mellitus. J Hypertens 1996,14(suppl 2):S89-S94.
4. Mimran A, Ribstein J: Microalbuminuria in essential hypertension. J Hum Hypertens 1996, 10:657-661.
5. Cerasola G, Cottons S, Mule G, Nardi E, Mangano MT, Andronico G, Contomo A, LiVecchi M, Galione P, Renda F et al.: Microalbuminuria, renal dysfunction, and cardiovascular complication in essential hypertension. J Hypertens 1996, 14:915-920. In this study the relationship between left ventricular mass index and microalbuminuria was carefully assessed.
6. Agrawal B, Berger A, Wolf K, Luft FC: Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens 1996, 14:223-228. The merit of this epidemiological cohort study is its size. Over 11000 patients were included in the analysis.
7. Goetz FC, Jacobs DR, Chavers B, Roel J, Yelle M, Sprafka JM: Risk factors for kidney damage in the adult population of Wadena, Minnesota. A prospective study. Am J Epidemiol 1997, 145:91-102. This epidemiological investigation identified smoking as a risk for microalbuminuria in the general population.
8. Orthe SR, Ritz E, Schrier RW: Renal risks of smoking. Kidney Int 1997, 51:1669-1677. This timely review draws attention to the little-appreciated fact that smoking is a major risk factor for the severity and progression of renal disease.
9. Hörner D, Riser D, Klimm HP, Ritz E: Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners. J Hypertens 1996, 14:655-660.
10. Mao Y, Desmeules M, Schaubel D, Beruhe D, Dyck R, Brule D, Thomas B: Inorganic components of drinking water and microalbuminuria. Environmental Res 1995, 71:135-140.
11. Jensen JE, Nielsen SH, Foged L, Holmegaard SN, Magid E: The micral test for diabetic microalbuminuria: predictive values as a function of prevalence. Scand J Clin Lab Invest 1996, 56:117-122. This investigation examines the predictive values of the immunoassay reagent strip, Micral.
12. Bar J, Hod M, Erman A, Friedman S, Gelernter I, Kaplan B, Boner G, Ovadia J: Microalbuminuria as an early predictor of hypertensive complications in pregnant women at high risk. Am J Kidney Dis 1996, 28:220-225.
13. North RA, Simmons D, Barnfather D, Upjohn M: What happens to women with preeclampsia? Microalbuminuria and hypertension following preeclampsla. Aust N Z J Obstet Gynaecol 1996, 36:233-238.
14. Nisell H, Lintu H, Lunell NO, Mollerstrom G, Pettersson E: Blood pressure and renal function seven years after pregnancy complicated by hypertension. Br J Obstet Gynaecol 1995, 102:876-881.
15. Karten J, Linne T, Wikstad l, Aperia A: Incidence of microalbuminuria In children with pyelonephritic scarring. Pediatr Nephrol 1996, 10:705-708.
16. Bigazzi R, Blanchi S, Baldari D, Sgherri G, Baldari G, Campese VM: Microalbuminuria in salt-sensitive patients: a marker for renal and cardiovascular risk factors. Hypertension 1994, 23:195-199.
17. Nesovic M, Stojanovic M, Nesovic MM, Ciric J, Zarkovic M: Microalbuminuria is associated with salt sensitivity In hypertensive patients. J Hum Hypertens 1996, 10:573-576.
18. Bang LE, Holm J, Svendsen TL: Retinol-binding protein and transferrin in urine. Am J Hypertens 1996, 9:1024-1028.
19. Bedir A, Özener IC, Emerk K: Urinary leucine aminopeptidase is a more sensitive indicator of early renal damage in non-insulin-dependent diabetics than microalbuminuria. Nephron 1996, 74:110-113.
20. Zimering MB, Eng J: Increased basic fibroblast growth factor-like substance in plasma from a subset of middle-aged or elderly male diabetic patients with microalbuminuria. J Clin Endocrinol Metab 1996, 81:4446-4452.
21. Enrica M, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997, 99:342-348. This study demonstrates that podocyte loss occurs in early diabetes. Whether similar changes occur in hypertensive non-diabetic patients with micro-albuminuria has not been determined.
22. Agrawal B, Wolf K, Berger A, Luft FC: Effect of antihypertensive treatment on qualitative estimates of microalbuminuria. J Hum Hypertens 1996, 10:551-555.
23. Alli C, Lombardo M, Zanni D, Maria A, Agrati M, Cassani M, Granata S: Albuminuria and transferrinuria in essential hypertension: effects of antihypertensive therapy. Am J Hypertens 1996, 9:1068-1076.
24. Molyneaux LM, Willey KA, Yue DK: Indapamide is as effective as captopril in the control of microalbuminuria in diabetes. J Cardiovasc Pharmacol 1996, 27:424-427.
25. The EUCLID study group: Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997, 349:1787-1792. This study lays the framework for commencing ACE inhibitor therapy in diabetic patients with microalbuminuria, even if they are not hypertensive.
26. Herztel C, Bosch J, Pogue J, Taylor DW, Zinman B, Yusuf S for the Hope study investigators: Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. Diabetes Care 1996, 19:1225-1227.
27. Palatini P, Graniero GR, Mormino P, Mattarei M, Sanzuol F, Cignacco GB, Gregori S, Garavelli G, Pegoraro F, Maraglino G et al. on behalf of the HARVEST study group: Prevalence and clinical correlates of microalbuminuria in stage I hypertension: results from the Hypertension and ambulatory recording Venetian study (HARVEST study). Am J Hypertens 1996, 9:334-341.